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Abstract Proteolysis of extracellular matrix is an
important requirement for embryonic development and is
instrumental in processes such as morphogenesis, angio-
genesis, and cell migration. Efficient remodeling requires
controlled spatio-temporal expression of both the proteases
and their inhibitors. Protein C inhibitor (PCI) effectively
blocks a range of serine proteases, and recently has been
suggested to play a role in cell differentiation and angio-
genesis. In this study, we mapped the expression pattern
of PCI throughout mouse development using in situ
hybridization and immunohistochemistry. We detected a
wide-spread, yet distinct expression pattern with prominent
PCI levels in skin including vibrissae, and in fore- and
hindgut. Further sites of PCI expression were choroid
plexus of brain ventricles, heart, skeletal muscles, uro-
genital tract, and cartilages. A strong and stage-dependent
PCI expression was observed in the developing lung. In the
pseudoglandular stage, PCI expression was present in distal
branching tubules whereas proximal tubules did not
express PCI. Later in development, in the saccular stage,
PCI expression was restricted to distal bronchioli whereas
sacculi did not express PCI. PCI expression declined in
postnatal stages and was not detected in adult lungs. In
general, embryonic PCI expression indicates multifunc-
tional roles of PCI during mouse development. The
expression pattern of PCI during lung development sug-
gests its possible involvement in lung morphogenesis and
angiogenesis.
Keywords PCI  Immunohistochemistry 
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Introduction
Protein C inhibitor (PCI, also known as SERPINA5;
reviews in Geiger 2007, Suzuki 2008) is a glycoprotein that
belongs to the serine protease inhibitor (serpin) family,
which includes both serine protease inhibitors and non-
inhibitory members (Rau et al. 2007; Silverman et al. 2001).
These serine protease inhibitors interact with the active sites
of their target serine proteases as suicide substrates by the
formation of covalent enzyme-inhibitor complexes, which
results in enzymatically inactive proteases. Many inhibitors
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of the coagulation and fibrinolytic cascades belong to the
serpin family, including antithrombin, heparin cofactor 2,
plasminogen activator inhibitor PAI-1 and 2, alpha-2 plas-
min inhibitor, and PCI (Rau et al. 2007). PCI is a multi-
functional serpin that can act both as a protease inhibitor of
the coagulation (activated protein C, factor Xa, factor XIa,
protein Z-dependent protease inhibitor and plasma kalli-
krein), the fibrinolytic (urokinase-type plasminogen acti-
vator (uPA) and tissue-type PA (tPA)), and the fertilization
system (acrosin and prostate specific antigen) (Christensson
and Lilja 1994; Ecke et al. 1992; Espana et al. 1989; Geiger
et al. 1989; Marlar and Griffin 1980; Meijers et al. 1988;
Suzuki et al. 1983; Zheng et al. 1994). It also acts as a non-
inhibitory serpin by binding retinoic acid (Jerabek et al.
2001) and by attenuating breast cancer cell growth,
metastasis and angiogenesis (Asanuma et al. 2007; Suzuki
and Hayashi 2007). A role of PCI in tissue repair and
regeneration has been suggested by its inhibitory action on
the activator of the hepatocyte growth factor (HGF; Hayashi
et al. 2007). In humans, PCI mRNA is expressed in many
tissues, including liver, kidney, pancreas, skin, and the male
and female reproductive organs (Geiger 2007; Krebs et al.
1999) while PCI protein was additionally found in different
body fluids, including plasma, urine, synovial fluid, sweat,
tears, milk, seminal plasma, Graaf follicle fluid, and cere-
brospinal fluid (Laurell et al. 1992). In rodents, PCI is
predominantly expressed in the male and female repro-
ductive organs (Uhrin et al. 2000; Wagenaar et al. 2000;
Wakita et al. 1998). In humans, the functional role in vivo
was tested in venous thrombosis, where elevated levels of
PCI constituted a mild risk factor for thrombosis (Meijers
et al. 2002) indicating that of the possible actions of PCI:
anticoagulant by inhibition of coagulation enzymes, anti-
antifibrinolytic by inhibition of the thrombin activatable
fibrinolysis inhibitor (TAFI) activation by thrombin-
thrombomodulin, anti-anticoagulant by inhibition of
activated protein C and protein C activation by thrombo-
modulin, and antifibrinolytic by the inhibition of urokinase,
the last two options predominate in vivo. In rodents, the
functional role of PCI has been studied in vivo in geneti-
cally modified mice (Hayashi et al. 2004; Nishii et al. 2006;
Uhrin et al. 2000; Wagenaar et al. 2000). Male homozygous
PCI deficient mice are sterile due to severely impaired
spermatogenesis probably caused by a disruption of the
Sertoli cell barrier (Uhrin et al. 2000). In transgenic mice
overexpressing PCI in multiple organs, including the lung,
the role of PCI in protection against monocrotaline-induced
pulmonary hypertension was described (Nishii et al. 2006).
Because little is known about embryonic expression of
PCI, we studied the spatial and temporal expression of PCI
during the development of the mouse.
We observed a tissue specific expression of PCI in
organs derived from all three germ layers. Some sites of
PCI expression suggest its involvement in the proteolysis
of extracellular matrix in connection with morphogenetic
processes and/or angiogenesis. A prominent and distinct
spatio-temporal expression pattern was found in the
developing lung which suggests a role for PCI in control-
ling ductal outgrowth and development of the capillary
plexus of sacculi and alveoli. Other sites of PCI expression
may suggest a role for PCI in developmentally important
cellular processes such as growth factor signaling.
Materials and methods
Animals
Mouse rearing and experiments were performed indepen-
dently in the labs in The Netherlands (in situ hybridization)
and in Austria (immunohistochemistry). The research
protocols were approved by the Institutional Animal Care
and Use Committee of the Universities of Utrecht and
Vienna. The FVB/NAU strain was used for in situ
hybridization and the mixed 129S/v:Swiss (50%:50%)
strain was used for immunohistochemistry. Timed-preg-
nant mice were kept in a 12 h dark-light cycle and fed a
standard chow diet ad libitum. Breeding pairs were allowed
access overnight. Pregnant mice were killed by decapita-
tion and embryos were delivered by hysterectomy after a
gestation of 8.5, 9.5, 10.5, 11.5, 12.5, 14.5 and 18.5 days
for in situ hybridization and after 9.5, 11.5, 12.5, 14.5 and
16.5 days for immunohistochemistry. Neonatal (at the day
of birth; spontaneous birth occurs 20 days after concep-
tion), days 1 and 2 and adult mice were sacrificed under
Nembutal anesthesia by transecting the abdominal blood
vessels and lungs were removed. Whole embryo’s
(embryonic days 8.5–16.5) and fetal (embryonic day 18.5),
neonatal days 1 and 2, and adult lungs were fixed with
buffered formaldehyde (4% paraformaldehyde in phos-
phate buffered saline, pH 7.4) for 24 h at 4C, and
embedded in paraffin after dehydration in a graded alcohol
series and xylene. From gestational days 8.5–16.5 whole
embryos were studied. Hereafter, tissue was removed due
to difficulties with sectioning of bony structures. Since
highest PCI expression was observed in the developing
embryonic lung, only lung tissue was studied in ED 18.5,
neonatal days 1 and 2, and adult mice.
In situ hybridization
Paraffin sections (7 lm) from embryonic and neonatal tis-
sue were cut and mounted onto 3-aminopropyltriethanol
silane coated slides (Henderson 1989). The in situ hybrid-
ization procedure was based on the method described by
Wilkinson (Wilkinson 1992; Wilkinson and Nieto 1993).
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Sections were deparaffined, digested with proteinase K
(Roche, Almere, The Netherlands), postfixed in 4% para-
formaldehyde, treated with 0.2 M HCl to block endogenous
alkaline phosphatase activity, acetylated with acetic anhy-
dride dissolved in triethanolamine and hybridized with
digoxygenine-labeled probe (5–50 ng per section) in
hybridization buffer overnight at 55C. The hybridization
buffer contained 9/10 (volume) hybridization mixture: 50%
formamide, 29 SSC, 19 Denhardt’s solution and 10%
dextran sulphate and 1/10 (volume) probe solution: 0.1–
1 ng/ll cRNA probe and 1 lg/ll yeast RNA in distilled
water. After hybridization, high stringency washing was
performed in 50% formamide/29 SSC at 55C. Sections
were treated with RNase A, rinsed in 29 SSC, blocked with
lamb serum (Invitrogen, Paisley, England) and incubated
with anti-digoxygenine-alkaline phosphatase conjugated
Fab fragments (Roche, Almere, The Netherlands) for 2 h.
Sections were washed extensively with Tris-buffered saline
(TBS; 100 mM Tris, 150 mM NaCl, pH 7.5) and incubated
with NBT/BCIP solution (Roche, Almere, The Nether-
lands), dissolved in 6% polyvinyl alcohol, overnight in the
dark. The staining reaction was terminated with TE-buffer
(10 mM Tris/HCl, 1 mM EDTA, pH 8.0). Subsequently,
sections were counterstained with nuclear fast red, dehy-
drated with an ethanol series, and mounted in Euparal. As
negative controls, hybridizations using sense probes or anti-
sense probes on RNase pretreated sections were performed,
which did not give any staining at all (Fig. 1b, d). We
studied a minimum of 3 animals per time-point.
Digoxygenine-labeled anti-sense cRNA probes to mouse
PCI were made by in vitro transcription using pBluescript
as a vector, containing the full length cDNA of mouse PCI
obtained from I.M.A.G.E. Consortium, CloneID, 680998
(Lennon et al. 1996).
Immunohistochemistry
Immune-staining was performed on paraffin sections using
antigen retrieval and signal enhancement as described
previously (Uhrin et al. 2007). In short, de-paraffinated
sections were incubated with 1% H2O2 in methyl alcohol
for 30 min to block endogenous peroxidase activity and
hydrated through a descending series of ethanol. Subse-
quently, antigen unmasking was achieved by steaming with
0.01 M citric acid buffer (pH 6.2) for 15 min. Slides were
washed in TBS and digested with 0.5 lg/ml proteinase K
(Roche Diagnostics, Vienna, Austria) in TBS supple-
mented with 2 mM CaCl2 for 2.5 min at 37C. After 4
washes for 10 min in TBS, sections were incubated with
10% BSA (bovine serum albumin, fraction V, Roche
Diagnostics, Vienna, Austria) in TBS for 30 min to reduce
unspecific binding of antibodies and with a mouse-specific
polyclonal rabbit anti-PCI antibody in TBS-BSA overnight
at 4C. The antibody was raised against recombinant
mouse PCI as described previously (Uhrin et al. 2000).
Hereafter, sections were incubated with a biotinylated goat
anti- rabbit antibody (Dako, Vienna, Austria) and peroxi-
dase-conjugated avidin (Vector, Burlingame, USA) in
TBS-BSA for 30 min at room temperature. After each
incubation, sections were washed 4 times for 10 min in
TBST (0.05 % Tween20 in TBS). After peroxidase activity
was visualized with metal-enhanced DAB (Roche Diag-
nostics, Vienna, Austria) sections were counter-stained
with methyl green, dehydrated in an ascending series of
ethanol and mounted with Eukitt.
For controls, the primary antibody was omitted which
resulted in no specific staining (Fig. 1f, h).
Results
Specificity of in situ hybridization and
immunohistochemistry detecting PCI expression
in mouse embryos
In situ hybridization using anti-sense probes resulted in a
distinct spatio-temporal expression pattern described below
whereas use of sense probes yielded no signal (Fig. 1a–d).
Likewise, immunohistochemistry where the first antibody
was omitted erased any specific signal (Fig. 1e–h).
Embryonic PCI expression on EDs 8.5–12.5
PCI mRNA expression as detected by in situ hybridization
was below the detection level on embryonic days (EDs)
8.5–10.5. PCI protein expression could be detected in the
developing embryonic myocardium of the heart tube from
ED 9.5 onwards (Fig. 2a).
On ED 11.5 and 12.5 PCI mRNA and protein expression
in the cranial region was detected in the epithelial cells of
the choroid plexus, which protrudes into the lumen of the
lateral and fourth ventricle (Fig. 2b) and in the developing
skin of the upper and lower jaws (Fig. 2c). In the thoracic
region PCI was expressed in the myocardium of the heart
(Fig. 2d) with decreasing staining intensity through devel-
opment, in the epithelial lining of the oesophagus (Fig. 2e),
and in the notochord (not shown, see Fig. 4h for later stage).
In the respiratory tract, PCI-positive cells were present in
the epithelial cells of the embryonic lung, whereas staining
was absent in the epithelial lining of the trachea (Figs. 2e–g,
3g in later stage). In the late embryonic, early pseudoglan-
dular stage of lung development PCI was already differen-
tially expressed in the bronchial epithelial cells showing
only expression in the most distally localized branching
bronchioli (Fig. 2f, g). PCI expression was present in the
oesophagus extending into the cardia region of the stomach
J Mol Hist (2010) 41:27–37 29
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(Fig. 2h, i). In the abdominal region, PCI label was found in
the developing reproductive organs, including the gonads
and in the urogenital sinus, in the (hind)gut and the skin of
the anal bay (Fig. 2h, j). Weak PCI expression in the
developing vertebrae could only be detected at the protein
level (not shown, see Fig. 4h for later stage).
Fetal PCI expression on EDs 14.5–16.5
On ED 14.5–16.5 in the cranial region PCI was expressed
in the developing brain in the choroid plexus (Fig. 3a), in
the epithelial lining of the nasal and oral cavities and in the
skin of the nose including developing vibrissae (Fig. 3b).
In the thoracic region highest PCI expression was
observed in the developing lung, which has proceeded
towards the late pseudoglandular stage of development.
PCI was expressed in the cuboidal bronchial epithelium of
the most distally localized branching bronchioli. Expres-
sion was absent in the proximal columnar epithelial cells of
the bronchioli and bronchi (Fig. 3c–f). PCI was present in
the epithelial lining of the oesophagus and was absent from
trachea (Fig. 3g). In addition, PCI expression could be
Fig. 1 Controls for detection of PCI expression in lung tissue at
embryonic days (ED) 14.5 (a–d) and 16.5 (e–h), respectively. In situ
hybridization with antisense (a, c) and sense (b, d) probes;
immunohistochemistry with (e, g) and without primary antibody (f,
h). (c, d, g, h) high power magnifications of boxed areas in (a, b, e, f).
Specific labeling can be found in distal branching tubules of the lung
(arrows), whereas proximal tubules are devoid of staining (asterisks).
The corresponding structures in controls are unstained (arrows,
asterisks). In controls of immunohistochemistry (f, h) the lumina of
blood vessels are slightly positive which is caused by the sensitive
amplification system able to detect biotin in residual mouse plasma.
In (a) PCI expression can also be observed within the cartilaginous
ribs whereas they are devoid of label in controls (b). Lu = lung,
Ri = ribs, VCI = vena cava inferior
30 J Mol Hist (2010) 41:27–37
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detected in the muscles of the thorax, intercostal muscles
and in the diaphragm (Fig. 3c, e, h).
In the abdominal region, PCI expression was largely
absent from liver and pancreas (Fig. 4a). PCI positive
labeling was found in oesophagus, in the proximal part of
stomach epithelia, and in a scattered pattern in epithelial
cells lining the gut (Fig. 4b, c). In urogenital organs, strong
expression was found in urethra (Fig. 4d), and weaker
expression was present in tubular epithelial cells of the
kidney (Fig. 4e, f). PCI was present in the tubular struc-
tures of the developing reproductive organs, including the
testis and epididymis (Fig. 4f). A high level of expression
was observed in the skin of the developing urogenital
region (Fig. 4d) whereas in other parts of the skin the level
of PCI expression varied (e.g. Figs. 4b, g, and 3b, h). In
addition, PCI was expressed in cartilages and in interdigital
Fig. 2 PCI expression at embryonic days (ED) 9.5 (a), 11.5 and 12.5,
respectively (b–j). In situ hybridization (b, c, e, g, i) and immuno-
histochemistry (a, d, f, h, j) on formaldehyde fixed paraffin sections.
a Early expression of PCI in myocytes of the heart at ED 9.5; b PCI
positive cells in choroid plexus (arrowheads) in the lateral ventricle
of the brain; c skin of upper and lower jaws; d PCI in myocardium at
ED 11.5; note absence of staining in non-myocardial cells including
the cushion material of the atrioventricular canal and the developing
valves in the outflow tract; e, presence of PCI in oesophagus and lung
and absence in trachea; f, g pseudoglandular stage of lung develop-
ment; note presence of PCI in distal tubules whereas proximal tubules
are devoid of staining (asterisks); h, i PCI in cardiac region of
stomach where the PCI-positive oesophagus enters (arrow) and in
gonad; j PCI expression in hindgut, urethra and skin of anal bay.
AB = anal bay, At = atrium, CM = cushion material, Go = gonad,
Hg = hindgut, LJ = lower jaw, Lu = lung, Oe = oesophagus,
OFT = outflow tract, St = stomach, To = tongue, Tr = trachea,
UJ = upper jaw, Ur = urethra, Ve = ventricle
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webs of the paws (Fig. 4g) and around intervertebral disks
of the vertebral column including the receding notochord
(Fig. 4h).
Postnatal PCI expression in the developing lung
In the early saccular stage of lung development on ED 18.5
PCI was expressed at high levels in the terminal bronchial
epithelium, whereas expression was low or even absent in
the sacculi (Fig. 5a, b). On neonatal days 1 and 2, when
lung development is still in the saccular stage, PCI was
expressed in epithelial cells of terminal bronchioli and at
very low levels in alveolar type 2 cells whereas alveolar
type 1 cells were negative (Fig. 5c–f). No PCI mRNA and
protein expression could be detected in adult lungs
(Fig. 5g, h).
Fig. 3 PCI expression in the head and thoracic region at embryonic
days (ED) 14.5 and 16.5, respectively. In situ hybridization (a, c, d)
and immunohistochemistry (b, e–h) on formaldehyde fixed paraffin
sections. High power magnifications of the boxed areas in (c, e) are
presented in (d, f). a Positive ependymal cells of choroid plexus;
b PCI expression in skin of snout, nasal cavity and developing
vibrissae; c thoracic and upper abdominal part at ED 14.5; note PCI
expression in lung, thoracal muscles (arrow), diaphragm (double
arrow), and intercostal muscles (arrowhead); d high power magni-
fication of boxed area in (c); pseudoglandular stage of lung
development with positive distal bronchioli, whereas proximal
tubules are negative (asterisks); e at ED 16.5 onset of ossification
in ribs with label in both cartilaginous and osseous compartments;
pseudoglandular stage lung; f high power magnification of boxed area
in (e) with positivity in distal branching bronchioli and no staining in
proximal tubules (asterisks); g PCI positive label in oesophagus but
not in trachea; h extremely latero-sagittal section through rib cage at
ED 14.5 shows PCI-positive intercostal and rib-cage muscles and in
skin. He = heart, Li = liver, LJ = lower jaw, Lu = lung, NC = na-
sal cavity, Oe = oesophagus, Ri = rib, To = Tongue, Tr = trachea,
UJ = upper jaw, Ve = ventricle
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Discussion
The serine protease inhibitor PCI (SERPINA5) has initially
been described in humans to be involved in the regulation
of hemostasis and fibrinolysis (Ecke et al. 1992; Espana
et al. 1989; Geiger et al. 1989; Marlar and Griffin 1980;
Meijers et al. 1988; Suzuki et al. 1983). Recently it became
clear that PCI fulfills many other functions under normal
and pathological conditions. Some functions where PCI is
involved, such as extracellular matrix remodeling, are
pivotal in embryonic developmental processes. Thus, we
mapped the expression pattern of PCI mRNA and protein
throughout mouse development.
Using immunohistochemistry, we first detected signal
on ED 9.5 whereas embryos at this stage were devoid of
label after in situ hybridization. It should be noted, that
Fig. 4 PCI expression in the abdominal region at embryonic days
(ED) 14.5 and 16.5, respectively. In situ hybridization (b–f) and
immunohistochemistry (a, g, h) on formaldehyde fixed paraffin
sections. a Little or no staining in liver, gallbladder and bile ducts,
intestine, pancreas; b, c strong PCI expression in oesophagus and
sporadic expression in gut epithelia; strong expression in skin of
hindlimb; d strong label in urethra and skin of anal bay; e scattered
label in tubules of kidney, in particular in branching ureter/collecting
tubules; f PCI expression in testis, epididymis, and kidney; g in paws
at ED 16.5, strong expression is found in skin, interdigital webs
(arrows) and in the zone of beginning ossification in diaphyses
(arrowheads); h in the vertebral column, PCI expression can be found
around areas of developing intervertebral discs (arrows) and in
nucleus pulposus (arrowhead) consistent with positive staining of
notochord in previous stages. AB = anal bay; CBD = common bile
duct; CD = cystic duct; CHD = common hepatic duct; Du = duo-
denum; Ep = epididymis; Gb = gallbladder; Gu = gut, Hl = hind-
limb; Ki = kidney, Li = liver, Oe = oesophagus, Pa = pancreas,
St = stomach; Te = testis; Ur = urethra
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initial experiments to detect PCI by immunohistochemistry
resulted in low signal intensity. Satisfactory signal intensity
was only achieved when antigen retrieval methodology and
signal amplification inherent to the biotin-avidin system
was applied. This approach likely resulted in a superior
level of sensitivity of immunohistochemistry over in
situ hybridization which may explain the discrepancy in
detection of the temporal onset of PCI expression using the
two methods.
The embryonic and fetal expression pattern of PCI
suggests involvement in different developmental processes.
However, it has previously been shown that PCI-deficient
(PCI-/-) mice were viable although PCI-/- males were
infertile (Uhrin et al. 2000). This suggests that the role of
PCI during development is redundant and other factors can
compensate for the lack of functional PCI levels. Conse-
quently, the exact role of PCI at the different expression
sites remains to be elucidated.
Fig. 5 PCI expression in the lung at embryonic day (ED) 18.5 (a, b),
postnatal days 1 (c, d) and 2 (e, f), and in adults (g, h). In situ
hybridization (a, b, e, f) and immunohistochemistry (c, d, g, h) on
formaldehyde fixed paraffin sections. a early saccular stage of lung
development (ED 18.5); strong label in columnar epithelia of terminal
bronchioli and some label in type 2 alveolar epithelial cells can be
observed; type 1 epithelial cells of sacculi are devoid of signal; b high
power magnification of boxed area in (a); c–f PCI expression at
postnatal days 1 (c, d) and 2 (e, f), lung in saccular phase; note PCI-
expression in terminal bronchii in Clara cells until the bronchoalve-
olar duct junction (arrows); faint staining of type 2 alveolar cells, type
1 alveolar cells are negative; d, f high power magnifications of boxed
areas in (c, e); g no PCI expression can be found in normal adult lung;
h high power magnification of boxed area in (g). S = sacculus,
TB = terminal bronchiolus
34 J Mol Hist (2010) 41:27–37
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Some sites of PCI expression are consistent with the
well characterized function of PCI in regulating extracel-
lular matrix proteolysis, which is of eminent importance
during morphogenesis. For instance, expression of PCI in
the developing hair anlagen of the snout falls into this
category. Another well established fact is the presence of
PCI in many body liquids such as in cerebrospinal fluid in
humans (Laurell et al. 1992). Thus it appears comprehen-
sible that PCI is expressed in the ependymal cells of cho-
roid plexus where the cerebrospinal fluid is secreted into
the ventricles.
Expression of PCI in the skin during mouse develop-
ment coincides with the previously described presence of
PCI antigen in the normal human epidermis and its con-
stitutive expression by keratinocytes in culture (Krebs et al.
1999) where PCI could provide protease inhibitory activity.
Further possible functions of PCI in the developing skin
might involve protection from active proteases present in
the amniotic fluid, such as uPA and tPA (Verkleij-Hagoort
et al. 2007), or regulation of morphogen or growth factor
supply in the epidermis, as PCI binds retinoids (Jerabek
et al. 2001) and hepatocyte growth factor (HGF) both
present in developing skin and amniotic fluid (Laurell et al.
1992; Srivastava et al. 1999).
Other sites of PCI expression are more difficult to rec-
oncile with known functions of PCI. Presence of PCI in the
interdigital webs of the paws and in the receding notochord
indicates involvement in cell death and apoptosis. To our
knowledge, no reports exist on direct involvement of PCI
in apoptosis so far. However, in endothelial cells activated
protein C (APC), which is inhibited by PCI, blocks p53-
induced apoptosis (Cheng et al. 2003). It is thus tempting to
speculate that PCI may act proapoptotic by binding of
repressive factors of apoptotic pathways or, alternatively,
PCI might be involved in triggering devascularization
which in turn might induce apoptosis by an indirect
mechanism. Furthermore, PCI protein could accumulate on
apoptotic cells, since it binds to phosphatidylserine (Mal-
leier et al. 2007), which is exposed on the surface of
apoptotic cells.
Concerning PCI expression in developing skeletal and
cardiac muscles, in a recent proteome analysis of differ-
entiating C2C12 muscle cells an up-regulation of serpins
was found and it was speculated that serpins may be
involved in myogenic differentiation and/or in myoblast
migration (Chan et al. 2007). Additionally, PCI might play
a role via interaction with HGF which has also been shown
to be involved in myoblast migration and muscle formation
(Dietrich et al. 1999).
The expression of PCI in developing gonads is of par-
ticular interest as we reported recently the expression of
PCI in post-natal and adult mouse testis (Uhrin et al. 2007)
and could previously show that PCI-/- mice display
severely impaired spermatogenesis (Uhrin et al. 2000). Our
data on the up-regulation of PCI on ED 12.5 are consistent
with a recent paper demonstrating sex-dimorphic gonadal
upregulation of PCI where PCI expression is found in
developing testes but not in ovaries (Odet et al. 2004).
Leydig cells were shown to be the source of PCI expression
and the authors speculate that PCI in Leydig cells might be
involved in the control of tissue proteolysis as Leydig cells
produce both PCI and its target protease uPA (Habert et al.
2001; Jerabek et al. 2001). It was proposed that PCI might
be involved in retinoic signaling because both Leydig cells
and PCI are targets of retinoids (Odet et al. 2004). Further
speculations about possible roles of PCI include regulation
of angiogenesis as developing testes display a more
extensive angiogenetic activity than ovaries.
PCI protein was also detected in cartilages where PCI
was present in areas of chondrocyte hypertrophy before
matrix degradation and onset of ossification. In vertebrae,
PCI was present in areas of future intervertebral discs.
Interestingly, in humans, serpins A1 and A3 have recently
been shown to be expressed in fetal cartilages, are up-
regulated during differentiation of cartilages (Pogue et al.
2004), and involvement of these serpins in matrix
homeostasis was hypothesized (Boeuf et al. 2008; Pogue
et al. 2004).
The absence of mouse PCI in the embryonic liver
coincides with our previous findings suggesting that PCI in
adult mouse, contrary to the situation in humans, is not a
plasma protein (Uhrin et al. 2000).
Concerning expression of PCI in the developing lung we
found that in the pseudoglandular stage PCI is expressed in
the most distally branching tubules. In the saccular phase,
PCI is expressed in the bronchiolar epithelia and is absent
from saccular epithelia. PCI expression ceases in the
perinatal period and is undetectable in adult lungs. Several
putative functions for PCI in the developing mouse lung
can be postulated: (1) PCI is directly involved in lung
morphogenesis participating in branching of the bronchi-
olar tree by controlling extracellular proteolysis; (2) PCI is
secreted into amniotic fluid and the lung may represent a
source of PCI production and secretion into the amniotic
fluid; (3) PCI could act through interaction with HGF
which is expressed in lung mesenchyme (Sonnenberg et al.
1993); (4) notably, PCI expression could not be detected in
the epithelia responsible for gas exchange in sacculi and
alveoli at later stages of development. PCI has recently
been shown to exert inhibitory effects on angiogenesis in a
tumor model in immuno-deficient mice, in Matrigel
implant assays and in rat corneal angiogenesis assays
(Asanuma et al. 2007). It was speculated that this effect
might be brought about by competition with the potent
angiogenesis-inducing factor VEGF for heparin binding
sites (Asanuma et al. 2007). Thus, down-regulation of PCI
J Mol Hist (2010) 41:27–37 35
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in alveoli could be necessary for alveolar capillarisation, a
hallmark of saccular phase of lung development and crucial
for proper post-natal lung functionality. Conversely,
expression of PCI in cuboidal epithelia of bronchi and
bronchioli may help to prevent this process.
In conclusion, we found that the expression patterns of
PCI show a tissue specific distribution during mouse
embryonic development. The data presented in this study
point to PCI as an important factor for mouse development.
On the other hand we reported previously, that, with the
exception of male infertility, all PCI-/- mice develop
phenotypically normal (Uhrin et al. 2000). This indicates
that the functions of PCI can be compensated by other
factors and it will be interesting to learn which factors are
able to take over the functions of PCI in PCI-/- mice.
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